Arent kendall

Although new evidence released by the American Cancer Culture attributes early detection to the sharp diminish in colorectal cancer deaths in the U.S., not adequately Americans are getting screened representing colorectal cancer, according to experts from the American College of Gastroenterology. Screening rates remain abysmal, equal though Medicare and sundry eremitical plans remit for screening tests.

While there has been significant improvement in also clientage awareness of colorectal cancer and screening, insufficient people realize that there are a bunch of simple screening tests that can make colorectal cancer one of the most preventable cancers. Early detection of colorectal cancer, when it is most treatable, shortly results in improved survival, exceeding 90 percent when detected at the earliest stages.

Colonoscopy remains the preferred screening strategy for colorectal cancer screening, according to the American College of Gastroenterology. Untypical other screening modalities, such as flexible sigmoidoscopy and fecal mystical blood test, colonoscopy is the alone test that can spot and remove pre-cancerous polyps from the colon during the same examination.

The ACG recommends men and women at middling risk in search colorectal cancer to begin screening at age 50. African-Americans should begin colorectal cancer screening as early as 45. To learn more yon the benefits of colorectal cancer screening and ban, speak with your doctor or affect http://www.acg.gi.org.

Physician Experts Available looking for Interviews

Physician experts on colorectal cancer screening are available for media interviews as March Colon Cancer Awareness Month.

Our physicians can approach devote:

– various colorectal cancer screening methods, including colonoscopy
– emergence of new screening technologies
– recent scientific developments in colorectal cancer baulk
– advice on the lifesaving potential of colorectal cancer screening
– screening recommendations for general to sharp-risk individuals, particularly African-Americans.

About Colorectal Cancer

Colorectal cancer is the bunch two cancer killer in the Allied States, affecting men and women equally. The American Cancer Society, in their 2008 Cancer Facts & Figures publication, estimates 148, 810 Americans will be diagnosed with colorectal cancer this year, and nearly 50,000 determination die from the complaint. Still, with screening and betimes detection, many of these deaths can be prevented. Most colorectal cancers develop from polyps, which are weirdo growths in the colon. Communistic undetected and rid to grow, some polyps may develop into cancer. Screening tests can find and remove precancerous polyps before they turn into cancer.

Colorectal Cancer Screening Recommendations

In the service of normal endanger individuals, the American College of Gastroenterology recommends screening dawning at age 50 (age 45 in place of African-Americans). The preferred screening test according to the American College of Gastroenterology is colonoscopy every 10 years. An alternative strategy for average risk individuals is an annual stool test for blood and a flexible sigmoidoscopic exam every 5 years. Distinct from colonoscopy, this approach does not allow identification and transference of polyps in the entire colon.

For those with a family history of colorectal cancer, testing should begin at 40 years of time eon or 10 years younger than the age of the youngest attacked relevant at the outdated of colon cancer diagnosis, whichever is earlier. For both usual and intoxication risk individuals, all covert precancerous polyps should be removed.

Earlier Screening Recommended for African-Americans: Begin at Epoch 45

African-Americans are diagnosed with colorectal cancer at a younger period than other ethnic groups, and African-Americans with colorectal cancer have decreased survival compared with other ethnic groups. Physician experts from the American College of Gastroenterology in 2005 issued new recommendations to healthcare providers to begin colorectal cancer screening in African-Americans at period 45 rather than 50. Colonoscopy is the preferred method of screening for colorectal cancer and text weather the recommendation that African-Americans begin screening at a younger ripen because of the increased frequency of colorectal cancer and a greater prevalence of proximal or swiftly-sided polyps and cancerous lesions in this population. The recommendations were published in the March 2005 issue of The American Newsletter of Gastroenterology.

Forth the American College of Gastroenterology

Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an oecumenical membership of more than 10,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive ailment specialist though its paralipsis on scholarly practice, teaching and research. The mission of the College is to help the evolving needs of physicians in the delivery of turbulent quality, scientifically sound, humanistic, ethical, and sell for-serviceable health care to gastroenterology patients.

American College of Gastroenterology (ACG)
6400 Goldsboro Rd., Ste 450
Bethesda, MD 20817
Pooled States
http://www.acg.gi.org

Molecular biologists at the University of California, San Diego include found one piece of the complex puzzle of autophagy, the process of “self-eating” performed by all eukaryotic cells — cells with a nucleus — to keep themselves in good health.

Their verdict, published in the March 11 outcome of the journal Developmental Cell, is well-connected because it allows scientists to steer this inseparable quality of cellular autophagy, and may lead actor to the ability to rule other selective “self-eating” processes. This, in amble, could help illuminate autophagy’s capacity in aging, immunity, neurodegeneration and cancer.

All eukaryotic cells dispose of bacteria, viruses, damaged organelles and other non-chief components through this self-eating activity. A part of the cell called the lysosome engulfs and degrades subcellular detritus. The ability of cells to recycle and reuse the cellular unembellished materials, as successfully as to “re-model” themselves in feedback to changing conditions, allows them to accustom and outlive.

Autophagy was first described about 40 years ago, but has recently enhance a topic of great interest in cell biology because it is linked to cell growth, development aging and homeostasis — helping cells to maintain a stability among integration, degradation and recycling.

The UC San Diego researchers report in their writing-paper that they identified a tale protein called Atg30 (one of 31 required throughout autophagy-related processes) from the yeast Pichia pastoris, that controls the degeneracy of a sub-cubby-hole of cells, the peroxisomes.

Peroxisomes generate and bestow of harmful peroxides that are by-products of oxidative chemical reactions.

Dissimilar organelles within the cell are degraded by lysosomes when the organelles are damaged or not necessary, said Jean-Claude Farré, the biologist who identified Atg30. The team is investigating peroxisomes, and working to twig how and why they are selected by the lysosome for baseness.

What the biologists found, he said, is that “this new protein can mediate peroxisome selection during pexophagy - that is, it is necessary for the sake of pexophagy, but not as far as something other autophagy-related processes.”

Suresh Subramani, a professor of biology who headed the party, said they have established that Atg30 is a “key player” in the selection of peroxisomes notwithstanding delivery to “the autophagy machinery” fitting for re-cycling.

“For the cardinal time, we can use a protein to be in control of the manage,” Subramani said. “It’s an important step in understanding the workings of cells.”

—————————-
Article adapted by Medical Word Today from inventive herd release.
—————————-

Subramani and Farré were assisted by Ravi Manjithaya and Richard D. Mathewson, all of the Division of Biological Sciences at UC San Diego.

The study was funded by grants from the National Institutes of Health.

Source: Paul K. Mueller

University of California - San Diego

People with HIV who are treated with anabolic steroids to prevent AIDS wasting may realize shame-faced gains in ballast and muscle mass, a new review shows.

The review covered 13 studies of adults age 24 to 42 with HIV, 294 of whom received anabolic steroids for at least six weeks and 238 of whom received placebo. The average weight increase in those taking anabolic steroids was nearly three pounds.

“The magnitude of weight gain observed may be considered clinically relevant,� said lead author Karen Johns, a medical assessment officer from the agency Health Canada. “One hopes there would be greater weight gain with the long-term use of anabolic steroids; however, this has not been proven to date in clinical trials.�

The review appears in the most recent issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

AIDS wasting, which leads to significant weight loss in people with HIV, causes severe loss of weight and muscle and can lead to muscle weakness, organ failure and shortened lifespan. Researchers have long sought to reverse this common, destructive effect of HIV with mixed success.

The wasting stems from loss of the body’s ability to grow muscle and from low levels of testosterone.

Anabolic steroids are synthetic substances similar to the male sex hormone testosterone that promote growth of skeletal muscle and the development of male sexual characteristics.

Although most recently in the news for their misuse by professional athletes, anabolic steroids have legitimate medical application for men with low testosterone and people with certain types of anemia. Two anabolic steroids available in the United States, nandrolone decanoate and oxandrolone, have been used to help increase weight and muscle mass in small studies of people with wasting.

Conversely, anabolic steroid use has been associated with increased rates of HIV in those who share needles or use nonsterile needles when they inject steroids.

In the review studies, anabolic steroids were administered to patients either orally or by injection. The main side effects were mild and included abnormal liver function tests; acne; mild increase in body hair; breast tenderness; increased libido, aggressiveness and irritability; and mood swings — all common side effect of anabolic steroid use.

“The risks and side effects of taking anabolic steroids long-term are certainly of concern,� Johns said. “We were unable to assess these risks in our review due to the short duration of treatment in the studies.�

Wayne Dodge, M.D., the HIV/AIDS program director at the Group Health Cooperative in Seattle, suggests that clinicians should obtain blood testosterone levels, “if an HIV-infected individual has had significant weight loss, significant fatigue or muscle wasting, and particularly if associated with a significant decrease in libido and erections. If [testosterone] is in the low or low-normal range then a trial of [steroids] could be tried. The individual and the clinician should decide what result would constitute a successful trial: weight gain of 15 pounds, a 30 percent improvement in sense of well-being [or] a successful erection once a week.�

The reviews authors conclude that further studies are needed to determine if increase in weight leads to improved physical functioning and quality of life, and ultimately increased survival, as well as the potential for serious side effects, especially with prolonged use.

By Lise Millay Stevens, Contributing Writer
Health Behavior News Service

Healthcare leaders gathered at the Keck School of Physic at the University of Southern California Fettle Science campus to chat about the critical issue of obesity and the challenges it brings to uninsured, under-insured, and humiliate-income communities. According to LA Common Health, limerick out of every five adults in LA County is portly (2005).

“Obesity is the most common guarantee b make amends for I am hearing to my questions connected with the state of modest health in the Collaborative States, markedly in our babies kids. It is critical for us to sport educate families on how to eat preferably and give people bigger tools to help themselves. To hear that our kids’ lifespan is prospering to be shorter than their parents’ due to poor eating habits is inconceivable. We induce to do something,” said Larry Regent, talk show host and founder of the Larry King Cardiac Foundation.

The Southern California Health Supervision Panel’s meeting - Health Crisis: Obesity and its Execute on Public Healthiness Care Systems. What’s Next? - was hosted by Larry Majesty and the Larry Ruler Cardiac Foundation in partnership with Los Angeles-based COPE Health Solutions, the Los Angeles County + University of Southern California (LAC+USC) Healthcare Network and the Keck School of Medicine of USC.

Today’s panel is meant to pick through awareness of a health turning-point that is preventable if children and adults take access to insight and salubriousness care severe to maintaining a healthy way of living. Being overweight or gross accounts for an estimated 3.43 billion in health care expenditures annually, or 9% of total fitness care costs (LA Public Health, 2003).

Health tow-haired attendee Marla Aguilar found out washing one’s hands of her blood screening at the health upright that her cholesterol was somewhat elevated. Her realization that this may be merited to her dietary decisions since her family could organize lifelong functional benefits instead of her and her three year old son Derek. “I am very opportune with the approachable service that I force often received at LAC+USC Medical Center,” said Ms. Aguilar, “I feel they are uncommonly delightful care of me and my son.”

The haleness panel was followed by a Low road to Fettle Fair at the new LAC+USC Medical Center in Boyle Heights in East Los Angeles. Attendees took part in free health screenings, such as blood pressure and bone density tests. Families were also encouraged to learn about the Camino de Salud Network of clinics. This Network not no more than improves the health of patients through enhanced access to and coordination of care, but it is a healthcare cream that encourages those without a primary care home to windfall their nearest community clinic.

“By providing these residents with a advise physician at a local health clinic through the Camino de Salud Network, people are getting the care they need and we are potentially saving lives,” said Allen Miller, CEO of COPE Health Solutions, program developer.

To find a clinic in the vicinity you visit, www.lacusc.org/CaminoDeSalud.

“At LAC+USC Medical Center, we impecuniousness to specify the most skilfully medical services plus more. Our partnership with COPE Well-being Solutions and the community clinics for the past three years has brought a wealth of information and handling to the people of our community. As long as we can indoctrinate people about different well-being crises like obesity - and assist them to find the right care, at the honourable place, at the rectitude in unison a all the same by decision a health clinic in their community for routine care and purloin managing chronic diseases - then we want persevere in to hotelier these fairs,” said Pete Delgado, President and CEO of LAC + USC Healthcare Network.

The Larry King Cardiac Underlying was established in 1988 to provide funding for life-extenuatory treatment for the sake of individuals, who, due to limited means or no protection, would be otherwise unable to receive the treatment and medical attention they so desperately exigency. www.lkcf.org.

COPE Robustness Solutions is a Los Angeles-based, non-profit healthcare corporation with a mission to - Compose Communities Healthier. In partnership with the LAC + USC Medical Center, COPE launched the innovative and proven Camino de Salud/Healthy Approach Network. Through the Network, every patient is provided with a primary worry home and nurse b like is coordinated between the clinic, hospitals, and specialists in order to maximize access to care and minimize unnecessary duplication and expensive services. COPE and its partners are redefining managed meticulousness not only in Los Angeles, but also in Kern County, Washington, D.C., and other communities throughout California and the country in procedure to make health be fond of more accessible and affordable allowing for regarding everyone. http://copehealthsolutions.org.

In the midst the largest teaching hospitals in the outback, LAC+USC has been a sharer with the Keck School of Nostrum of the University of Southern California since 1885. Staffed by more than 500 in toto completely-time privilege of the Keck Educational institution of Medicine and almost 900 medical residents, LAC+USC currently admits more than 40,000 inpatients and handles nearly 200,000 danger department visits and 1 million ambulatory care visits each year. The medical center provides major regional and community difficulty trauma and critical care services supply other clinical circumspection activities. Construction of the $1 billion LAC+USC Medical Center Replacement Facility is instanter complete and opened on November 7.

USC.s Keck School of Medicine trains tomorrow’s leaders in patient mindfulness and biomedical inquire into and provides advanced fitness be responsible for to the people of Southern California at USC.s 45-acre Robustness Sciences Campus. The Keck School is proud of its historic partnership with the LAC+USC Medical Center, where USC physicians concern as far as something patients at at one of the surroundings largest teaching hospitals. The Keck School of Medication is also home to the USC Cardiovascular Thoracic Organization, an innovator in cardiac acquiescent care. www.usc.edu/keck

Researchers at the Joslin Diabetes Center have shown that insulin-producing pancreatic beta cells can model after birth or after injury from precursor cells within the pancreas that were not beta cells, a finding that contradicts a widely-cited earlier learning that had concluded this is not conceivable.

The study, published online this week in the Proceedings of the National Academy of Sciences Early Edition, identifies the source of the progenitor cells as being pancreatic duct cells.

“This means that there is a population of pancreatic cells that can be stimulated, either within the body or outside the body, to become new beta cells, the cells that are lacking in diabetes,” said Susan Bonner-Weir, Ph.D., the study’s lead researcher and a Senior Investigator in the Section on Islet Transplantation and Cell Biology at Joslin and Associate Professor of Medicine at Harvard Medical School.

The experiments, conducted in animal models, suggest a new source of beta cells for replacement therapy to treat or cure diabetes.

In type 1 diabetes, the pancreas produces little or no insulin since the insulin producing beta cells are destroyed by the body’s own immune system. While transplantation of human islets from donor pancreases has been successful in getting people with type 1 diabetes off insulin treatment, this insulin independence is only successful for a few years.

“One of the problems with islet transplantation is that while the proof of principal is there, we don’t have enough islets to transplant and they go through a traumatic process during isolation,” said Bonner-Weir. “Many islets are not in the greatest condition after being isolated from a pancreas.”

The two major obstacles to islet transplants are the need for continued use of immunosuppressive drugs to prevent both rejection and return of autoimmune destruction and the lack of a reliable source of insulin producing islet cells.

Bonner-Weir’s main research focus is the search for new sources of insulin-producing islet cells. In this study, in experiments in mice, Bonner-Weir’s group used a similar lineage tracing system employed by a group from Dr. Douglas Melton’s lab at Harvard. That group concluded in a paper published in Nature in 2004 that after birth, new beta cells only result from division of preexisting beta cells and that beta cells do not form from progenitor cells after birth.

“That conclusion, coming from such a well-respected group, was taken by many as fact and cast a cloud over this important research area,” Bonner-Weir said.

However, earlier this year a group led by Xiaobo Xu in Belgium showed that islet progenitor cells within the adult pancreas could be activated to increase the number of beta cells by the process of differentiation rather than self-duplication, but the paper did not indicate the origin of these cells.

Bonner-Weir’s paper complements the Belgium study by identifying the source of these cells as pancreatic duct cells.

In addition to finding that these duct cells can differentiate into insulin producing islet cells after birth and in regeneration after injury, the study showed that they can also become new acinar cells, a finding that has potential implications for pancreatic cancer, since the origin of the cancerous cells has been disputed.

Two lineage tracing experiments involved genetically marking the ductal cells and then following them. The first experiment, which involved one-month-old mice, found that between 30 to 40 percent of islets had beta cells that had formed after birth from duct cells. In the second experiment, conducted in adult mice, the Joslin researchers used same regeneration model employed in the Belgian study which is based on tying off the main pancreatic duct. Beyond the area of the tie some cells die, but others grow to regenerate the whole structure. In these adult mice, new islets and new acinar cells were again shown to have been formed from the preexisting duct cells.

“Our data provide strong support to the concept of a shared lineage of ductal, acinar and islet cells after birth, even in the adult. This means that there is a population of cells - we don’t know if it is all of the cells or just some - that can be stimulated to become new islet cells,” Bonner-Weir said.

She concluded: “Our identification of a differentiated pancreatic cell type as an in vivo progenitor for all differentiated pancreatic cell types has implications for a potential expandable source for new islets for replacement therapy for diabetes. While the ideal therapy would be to have those with diabetes regenerate their own islet cells, that is still a long way off.”

This study was supported by grants from the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, the Juvenile Diabetes Research Foundation and the Diabetes Wellness Foundation as well as a number of private donors.

Others participating in the research included: Akari Inada, Cameron Nienaber, Hitoshi Katsuta, Jared Levine, Rita Morita and Arun Sharma, all of Joslin, and Yoshio Fujitani of Vanderbilt University.

http://www.joslin.org/

The Russian government has approved a five-year, $2.9 billion draft program to contend diseases, including HIV/AIDS, in an trouble to improve the country’s sentience expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).

The program also aims to provide 30,000 HIV-positive people in the country with access to treatment.

According to the Federal AIDS Center, about 18,000 out of the 58,000 HIV-positive people in need of treatment have access to it, the Moscow Times reports.

Health and Social Development Minister Mikhail Zurabov said that the HIV/AIDS segment of the program is an “essential step forward,” adding that a few years ago, only 700 people in Russia had access to treatment.

The government also needs to provide information about prevention and treatment services to the Russian public, Mikhail Rukavishikov, head of the Society of People Living With HIV, said (Osadchuck, Moscow Times, 2/26).

According to the state statistics agency, Russia’s population in 2006 decreased by more than 560,000 people and was recorded at 142.2 million — a new post-Soviet era low (AP/Guardian, 2/23).

In addition, deaths outnumber births by at least 50% in many parts of the country (ITAR-TASS, 2/21).

According to an unnamed health ministry official, life expectancy for men in Russia in 2005 was 58.9 years, 15 to 20 years shorter than for men in France, Japan and the U.S.

For Russian women, life expectancy was 72.3 years, four to seven years shorter than for their French, Japanese and U.S. counterparts (AP/Guardian, 2/23).

According to medical experts, the country’s low life expectancy is because of unhealthy lifestyles — including high rates of smoking and alcohol abuse — and increasing levels of injection drug use and suicide.

The prevalence of HIV/AIDS, TB and other infections have risen since the end of the Soviet era, with injection drug users, alcoholics and prisoners most affected.

Health aid groups say HIV prevalence has almost doubled in Russia since 2001 (CBC News, 2/22).

In addition, Zurabov on Thursday said one-tenth of migrant workers in Russia are living with TB, HIV/AIDS or hepatitis because of inadequate health checks (Reuters, 2/22).

Russian and international medical experts have said that the government has not taken action to address the country’s health crisis and that it has denied the extent of the issue.

Prime Minister Mikhail Fradkov said the government aims to “tackle the problem seriously” by “providing adequate funding” for diseases, including TB and HIV/AIDS (BBC News, 2/22).

According to Zurabov, half of the funding for the health program will come from regional budgets.

He added that Russia’s provinces did not reach funding goals for the previous program, which expired in 2006.

Zurabov urged provinces to improve their performance. For the previous program, which ran from 2002 through 2006, allocations totaled roughly $750 million (AP/Houston Chronicle, 2/22).

This article is republished with sort permission from our friends at the The Kaiser Family Foundation. You can vision the entire Kaiser Daily Health Practice Statement, search the archives, or witness up concerning email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Robustness Principles Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Division Foundation. Copyright 2007 Notice Board Company and Kaiser Family Foundation. All rights guarded.

Researchers studying nearly 6,000 patients in intensive care units (ICUs) in 13 hospitals everywhere the Netherlands, found that giving antibiotics as
a safeguard measure to ICU patients increased their chances of survival.

The study was the work of first author Dr. Anne Marie de Smet, an anesthesiologist-intensivist at the Arm of Perioperative and Crisis Care of
the University Medical Center (UMC) Utrecht in The Netherlands, and colleagues, and is published in the 1 January 2009 issue of the New
England Journal of Remedy, NEJM.

Two types of antibiotic treatment are time after time inured to to bring to a halt infection in some ICU patients: selective oropharyngeal decontamination (SOD,
administered via the mouth) and discriminative digestive tract decontamination (SDD, straight into the digestive tract). But so widely studies examining the
effectiveness of these methods require shown conflicting results, wrote the authors in their CV information.

For the learn about, de Smet and colleagues compared exemplar ICU care with the effect of these two types of antibiotic treatment by putting identically 5,939
patients into individual of these three treatment groups. The patients, who were hospitalized in ICUs between 2004 and 2006, were selected for the treatment of the swot
because they were either expected to be be in ICU in compensation at three days and/or to be intubated (on a ventilator) for at least two days.

In the SOD group, 1,904 patients received an articulated antibiotic paste four times a day. In the SDD group, 2,045 patients also received the oral paste four
times a day plus they were also dedicated antibiotics via a gastric tube into the intestinal article and also via intravenous drip. In the restraint set apart, 1,990
patients received standard ICU circumspection.

The results showed that:

• After 4 weeks, fewer patients had died in the antibiotic groups than in the control group (26.6 per cent in the SOD, 26.9 per cent in the SDD, and 27.5 per cent in
  the control group).
• Preventive use of antibiotics in the SDD group reduced deaths by 3.5 per cent, and the SOD group by 2.9 per cent compared to the control
  group.
• There was no significant difference between the two antibiotic groups in measured outcomes.
• Also, there was no increase in the number of antibiotic-resistant bacteria among patients in the antibiotics groups.
• Although the patients in the control group were in a slightly more serious condition, the researchers took this into account and adjusted the results
  to rule out this effect.

The authors concluded that:

“In an ICU population in which the mortality rate associated with measure care was 27.5 per cent at day 28, the rate was reduced by an estimated 3.5
interest points with SDD and by 2.9 percentage points with SOD.”

De Smet said the findings are clearly conclusive and help to settle a big running ponder over concerning whether the advantages of using antibiotics to prevent
infection overcome the possibility of developing antibiotic resistance.

“I put faith we should revise the antibiotic method for the ICU,” said De Smet.

“Because the chew over was conducted in thirteen Dutch hospitals, the conclusions can be implemented completely the country. We have seen that using
antibiotics clearly results in a reduction in the number of deaths, and ICUs should put out use of this experience,” she added.

Even so, while these results are promising, the study focused on diminutive relations results, and further investigation is needed to winnow whether defiance to
antibiotics would elaborate on in the longer term.

Every year in the Netherlands, more than 18,000 patients spend more than three days in ICUs.

“Decontamination of the Digestive Tract and Oropharynx in ICU Patients.”
de Smet, A.M.G.A., Kluytmans, J.A.J.W., Cooper, B.S., Mascini, E.M., Benus, R.F.J., van der Werf, T.S., van der Hoeven, J.G., Pickkers, P., Bogaers
-Hofman, D., van der Meer, N.J.M., Bernards, A.T., Kuijper, E.J., Joore, J.C.A., Leverstein-van Hall, M.A., Bindels, A.J.G.H., Jansz, A.R., Wesselink,
R.M.J., de Jongh, B.M., Dennesen, P.J.W., van Asselt, G.J., te Velde, L.F., Frenay, I.H.M.E., Kaasjager, K., Bosch, F.H., van Iterson, M., Thijsen,
S.F.T., Kluge, G.H., Pauw, W., de Vries, J.W., Kaan, J.A., Arends, J.P., Aarts, L.P.H.J., Sturm, P.D.J., Harinck, H.I.J., Voss, A., Uijtendaal, E.V., Blok,
H.E.M., Thieme Groen, E.S., Pouw, M.E., Kalkman, C.J., Bonten, M.J.M.
Recent England Journal of Medicine, NEJM January 1, 2009, Vol 360, Total 1, pages 20 - 31.

Click here on Condense.

Sources: Journal abstract, University Medical Center Utrecht.

Written by: Catharine Paddock, PhD

Copyright: Medical News Today

Not to be reproduced without permission of Medical Gossip Today

Measurement of all fertility hormones is generally speaking performed between light of day 3 and 5 of a women’s hormonal cycle with a view the diagnosis of menorrhea problems, onset of menopause and infertility. Having to polish off each exam alone has cost and time implications.

Randox has developed a podium where multiple analytes can be tested simultaneously on a biochip with a niggardly quantity of blood. The Randox fertility panel includes follicle-stimulating hormone (FSH), luteinising hormone (LH), estradiol, progesterone, testosterone and prolactin. FSH and LH, produced in the hypothalamus, wake up the ovaries and the uterus to prime the female body in support of ovulation and implantation. Estradiol and progesteroneare also twisted in this process, but are produced mainly in the ovaries. All hormones are interdependent on a enduring adversary feedback apparatus. Testosterone is the main manful hormone, but also produced by women in small quantities. Prolactin is produced in the pituitary gland and stimulates the growth of the mammary glands and the presentation of milk after childbirth.

Biochip technology enables coinciding testing of all co-dependent hormones and can give valuable information of a woman’s hormonal stature. Diagnostically significant values can show the make of the underlying conundrum, and will instigate more distant suited interrogation.

Randox is an international diagnostics ensemble, headquartered in the UK. Randox develop, manufacture and furnish clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; supremacy controls and EQA; environmental diagnostics; recombinant proteins and antibodies in search sprightliness sciences.

http://www.randox.com

Examination drug information on Estradiol.

Women age 65 years or older constitute half of new tit cancer patients each year, and the number of older women with mamma cancer is prognosticate to double by 2030 as the baby boomers lifetime. Yet despite their increasingly large numbers, older women who broaden mamma cancer in many cases fail to receive the same care as offered to younger women according to Jeanne Mandelblatt, M.D., of Georgetown University’s Lombardi Comprehensive Cancer Center.

In an column entitled “Treating Heart of hearts Cancer: The Age Familiar Dilemma of Familiar Age” which appears in the September 20, 2006, issue of the Journal of Clinical Oncology, she calls on doctors treating breast cancer in older women to look beyond the year in which a char was born and to bilk into account her overall health, frailty and ability to tolerate various cancer treatment.

“Older women who feel more ageism in their interaction with providers are less indubitably to learn radiation or chemotherapy,” Mandelblatt wrote.

Women want their physicians to consider their malady, not their birthdays. “In our work with older women, we found that 33 percent would choose chemotherapy if it would extend their lives by 12 or more months,” she said.

Older women in chattels health may do better than younger women in poorer health. “At this then, we do not sine qua non more research to document what we already have knowledge of: older women get less comprehensive treatment. What we need is an competence of the biology of cancer in this citizenry [women 65 or older with titty cancer], tools that can help clinicians catalogue physiological reserve and adeptness to withstand the rigors of more warlike treatment, and more consistent elicitation of women’s intelligent preferences.”

All round Lombardi Thorough Cancer Center
The Lombardi Encyclopaedic Cancer Center, for all practical purposes of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative prime and clinical research, patient mindfulness, community lore and outreach, and the training of cancer specialists of the future. Lombardi is a specific of only 39 full cancer centers in the nation, as designated by the National Cancer Launch, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu/.

—————————-
Article adapted by Medical News Today from original prod press.
—————————-

Contact: Cindy Fox-Aisen

Georgetown University Medical Center

– Alex Mihailidis, a professor of Occupational Psychotherapy at the University of Toronto, has developed a technology called TEACHER, which directs people with Alzheimer’s on account of the task of washing their hands. He is refining the technology to personalize it so it will be adept to take under one’s wing verbal and visual prompts that are tailored to the needs of each himself. For more information see:
http://www.ot.utoronto.ca/iatsl/Projects/IntellEnviros.htm and the article “Safer Seniors” which appeared in U of T’s Announcement newspaper and on its spider’s web plot:
http://www.news.utoronto.ca/bin6/040901-411.asp

It is about another project by Dr. Mihailidis, which will help detect when an elderly himself has had a slope.

Contact: Alex Mihailidis, 416-946-8565, alex.mihailidis@utoronto.ca

– Professors Ronald Baecker and Elsa Marziali make use animation and video to pick up Internet-based tools that instruct in skills to caregivers of people with dementia. A video-conferencing system has been developed to allow a squad of people who are caring for people with dementia to link up online to the core a web site which also provides links to facts about diagnosis and treatment.

Recently-announced funding will be used to improve the network site with a video and power point library on various topics representing caregivers, and to broaden multimedia video histories of patients with dementia and test the value of these histories in requital for the patients and their caregivers.

Reach:

Ronald Baecker, Bell University Laboratories Professor of Human-Computer Interaction at the U of T, 416-978-6983, rmb@kmdi.utoronto.ca

or

Elsa Marziali, Schipper Chair in Gerontological Social Charge Enquiry at Baycrest Centre on account of Geriatric Care, Director of the Katz Focal point and Professor of Societal Work, 519-599-6968 (Aug. 31 to Sept. 3) and 416-978-2500, ext. 2284 (after Sept. 8), elsa.marziali@utoronto.ca

Both projects were recently given funding by the Alzheimer’s Association and Intel Corporation: See http://www.alz.org/Media/newsreleases/2004/083004_grants.asp

Janice Walls
News Services Officer
University of Toronto
416-978-5948
janice.walls@utoronto.ca